Foghorn Therapeutics (FHTX) Stock Chart & Stock Price History $5.23 -0.15 (-2.79%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$5.36 +0.14 (+2.58%) As of 02/21/2025 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Foghorn Therapeutics Stock Price Performance 5 Day Performance-14.68%1 Month Performance+19.68%3 Month Performance-33.29%6 Month Performance-30.36%Year-To-Date Performance+10.81%1 Year Performance-14.12% Receive FHTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Foghorn Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address FHTX Stock Chart for Saturday, February, 22, 2025 FHTX Chart by TradingView Foghorn Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$5.38$5.23-2.79%$5.54$5.08183,495 shs$290.85 million02/20/2025$5.87$5.38-8.35%$6.27$5.36173,069 shs$299.18 million02/19/2025$5.96$5.87-1.51%$6.12$5.68139,703 shs$326.43 million02/18/2025$6.13$5.96-2.77%$6.66$5.82210,618 shs$331.44 million02/17/2025$6.13$6.13$6.50$6.01179,094 shs$340.89 million02/14/2025$6.16$6.13-0.49%$6.50$6.01179,094 shs$340.89 million02/13/2025$5.52$6.16+11.59%$6.31$5.41206,157 shs$342.56 million02/12/2025$5.37$5.52+2.79%$5.72$5.32125,987 shs$306.97 million02/11/2025$5.29$5.37+1.51%$5.49$5.11255,517 shs$298.63 million02/10/2025$4.75$5.29+11.37%$6.19$5.08572,279 shs$294.18 million Get the Latest News and Ratings for FHTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Foghorn Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$4.12$4.75+15.29%$4.77$4.09243,252 shs$264.15 million02/06/2025$4.37$4.12-5.72%$4.56$4.0881,911 shs$229.11 million02/05/2025$4.11$4.37+6.33%$4.51$3.96111,624 shs$243.02 million02/04/2025$3.98$4.11+3.27%$4.26$3.90113,026 shs$228.56 million02/03/2025$4.19$3.98-5.01%$4.22$3.8995,068 shs$221.33 million01/31/2025$4.34$4.19-3.46%$4.64$4.05118,325 shs$233.01 million01/30/2025$3.98$4.34+9.05%$4.46$4.0582,312 shs$241.36 million01/29/2025$4.10$3.98-2.93%$4.10$3.8675,771 shs$221.25 million01/28/2025$4.12$4.10-0.49%$4.21$4.0187,983 shs$227.92 million01/27/2025$4.06$4.12+1.48%$4.39$3.9784,634 shs$229.03 million01/24/2025$4.38$4.06-7.31%$4.43$3.92121,661 shs$225.70 million01/23/2025$4.37$4.38+0.23%$4.48$4.2461,829 shs$243.48 million01/22/2025$4.41$4.37-0.91%$4.45$4.1991,784 shs$242.94 million01/21/2025$4.31$4.41+2.32%$4.52$4.17114,952 shs$245.15 million Related Companies Indivior Stock Chart Nurix Therapeutics Stock Chart Vir Biotechnology Stock Chart Syndax Pharmaceuticals Stock Chart Arvinas Stock Chart ANI Pharmaceuticals Stock Chart Day One Biopharmaceuticals Stock Chart Adaptive Biotechnologies Stock Chart Arcus Biosciences Stock Chart Calliditas Therapeutics AB (publ) Stock Chart Receive FHTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Foghorn Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:FHTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Foghorn Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Foghorn Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
